- Home
- RELL vs PLX Comparison
RELL vs PLX Comparison
Compare RELL & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- PLX
- Stock Information
- Founded
- RELL 1947
- PLX 1993
- Country
- RELL United States
- PLX United States
- Employees
- RELL N/A
- PLX N/A
- Industry
- RELL Electronic Components
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RELL Technology
- PLX Health Care
- Exchange
- RELL Nasdaq
- PLX Nasdaq
- Market Cap
- RELL 139.9M
- PLX 127.4M
- IPO Year
- RELL N/A
- PLX 1998
- Fundamental
- Price
- RELL $9.73
- PLX $1.42
- Analyst Decision
- RELL
- PLX Strong Buy
- Analyst Count
- RELL 0
- PLX 1
- Target Price
- RELL N/A
- PLX $15.00
- AVG Volume (30 Days)
- RELL 33.0K
- PLX 546.0K
- Earning Date
- RELL 07-23-2025
- PLX 08-13-2025
- Dividend Yield
- RELL 2.47%
- PLX N/A
- EPS Growth
- RELL N/A
- PLX N/A
- EPS
- RELL N/A
- PLX 0.05
- Revenue
- RELL $208,909,000.00
- PLX $59,764,000.00
- Revenue This Year
- RELL $5.95
- PLX $10.00
- Revenue Next Year
- RELL $13.59
- PLX $83.13
- P/E Ratio
- RELL N/A
- PLX $29.48
- Revenue Growth
- RELL 6.34
- PLX 0.18
- 52 Week Low
- RELL $7.57
- PLX $0.82
- 52 Week High
- RELL $15.51
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- RELL 47.50
- PLX 43.15
- Support Level
- RELL $9.58
- PLX $1.41
- Resistance Level
- RELL $10.75
- PLX $1.53
- Average True Range (ATR)
- RELL 0.45
- PLX 0.07
- MACD
- RELL -0.07
- PLX 0.00
- Stochastic Oscillator
- RELL 11.80
- PLX 4.35
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.